100% of moneycontrol users recommend buying Parabolic Drugs.
What's your call on Parabolic Drugs today?
Read 14 investor views
|Company Name||Last Price||%
|Dr Reddys Labs||3260.00||0.96||3353.85||2420.00||55,539.26|
|Mar' 14||Sep' 13||Jun' 13||Mar' 13|
|No Mutual Funds Holding the share|
Kwality Recommended on Jun 25th 2014
Recommended price 45.00 | Peak from reco 58.00 28.89%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Parabolic Drugs is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 85.41 crore.The company has reported a standalone sales of Rs 112.05 crore and a Net Loss of Rs -61.01 crore for the quarter ended Mar 2014.
The company management includes Pranav Gupta - Chairman & Managing Director, Vineet Gupta - Whole Time Director, Balbir Singh Bhasin - Director, Arun Mathur - Director, Nikhil Goel - Director, Balwan Bansal - Director.
It is listed on the BSE with a BSE Code of 533211 and the NSE with an NSE Code of PARABDRUGS.
Its Registered office is at S.C.O 99-100, Top Floor,,Sector 17 - B Chandigarh,Chandigarh - 160017.
Their Registrars are Link Intime India Pvt. Ltd.